3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
21
Terminated
9
Recruiting
9
Withdrawn
2
Active not recruiting
2
Unknown
1
Sponsor Class
OTHER
114
OTHER_GOV
6
INDUSTRY
4
NIH
3
UNKNOWN
1
NETWORK
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
15
Paclitaxel
14
Taxes
10
Cyclophosphamide
9
Carboplatin
9
Gemcitabine
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Trastuzumab
5
Radiotherapy
5
Oxaliplatin
5
Doxorubicin
5
Docetaxel
5
Cytarabine
5
Capecitabine
5
Brachytherapy
5
fludarabine
4
Rituximab
4
Radiosurgery
4
Fluorouracil
4
Dexamethasone
4
Watchful Waiting
3
Radiotherapy, Intensity-Modulated
3
Pemetrexed
3
Nimorazole
3
Lenalidomide
3
Imatinib Mesylate
3
Idarubicin
3
Gene Expression Profiling
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
NETWORK
×
Surgical Procedures, Operative
×
Clear all
NCT01753414
2025-01-06
POSTILV
Radiation Therapy Oncology Group
Phase 2
Unknown
44 enrolled
20 charts